Receptors, sigma, antagonists & inhibitors
- Name
- Receptors, sigma, antagonists & inhibitors
- Accession Number
- DBCAT005010
- Description
Not Available
- Drugs
Drug Drug Description Arylacenamide Investigated for use/treatment in cancer/tumors (unspecified), immunosuppressive, and prostate cancer. E-52862 Not Annotated - Drugs & Drug Targets
Drug Target Type Arylacenamide HCG20471, isoform CRA_c target